Navigation Links
World TB Day Senate Briefing
Date:3/23/2010

WASHINGTON, March 23 /PRNewswire-USNewswire/ --

What:

A Senate briefing, Bringing Established Methods to Scale: New Perspectives in the Changing World of TB, to discuss TB and drug-resistant TB, including multidrug-resistant TB (MDR-TB) and extensively-drug resistant (XDR-TB), the impact on global health and the current state of surveillance, diagnosis and treatment around the world.

Who:

Co-hosts include the Global Health Council, American Thoracic Society, Stop TB Partnership and The Lilly MDR-TB Partnership.

Speakers:

  • Dr. Ernesto Jaramillo, Team Leader for MDR-TB, Stop TB Department, World Health Organization
  • Dr. Rachel Nugent, Center for Global Development - MDR-TB and its relation to global health
  • Dr. Celine Gounder, Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE) - The combined TB and HIV epidemic and the effects of community-based research

Moderator: Smita Baruah, Global Health Council

When:

World TB Day, Wednesday, March 24, 2010, 10:00 a.m.11:30 a.m. ET

Where:

Hart Senate Office Building, Room SH-902

Washington, DC

Why:

This year's World TB Day marks the midway point for the Global Plan to Stop TB. The plan's goals are to expand equitable access for all to quality TB diagnosis and treatment; to treat 50 million people; to save 14 million lives; to introduce in 2010 the first new TB drug in 40 years; to detect active TB through diagnostic tests at the point of care allowing rapid, sensitive and inexpensive detection by 2010; and to have a new, safe, effective and affordable vaccine by 2015.

Current TB statistics:

  • There were 9.4 million new TB cases in 2008, including 1.4 million cases among people living with HIV(1)
  • 1.8 million people died from TB in 2008, including 500,000 people with HIV - equal to 4,500 deaths a day(1)
  • TB is a leading killer of people with HIV(1)
  • Today's TB drugs are more than 40 years old and must be taken for at least six to nine months for drug-susceptible tuberculosis(2)
  • MDR-TB is a form of TB that is difficult and expensive to treat and fails to respond to standard first-line drugs. (1)  There were an estimated 500,000 new MDR-TB cases in 2007. Just over 1% of cases were receiving treatment in 2008 known to be based on WHO's recommended standards(1)
  • XDR-TB, which occurs when resistance to second-line drugs develops on top of MDR-TB, been found in 57 countries to date(1)

For more information, please go to http://www.globalhealth.org/news/article/12157

(1) "2009 Update Tuberculosis Facts;" http://www.who.int/tb/publications/2009/tbfactsheet_2009update_one_page.pdf  World Health Organization, Stop TB Partnership. 18 Mar. 2010

(2) "Mission and History;" http://www.tballiance.org/about/mission.php. TB Alliance. 18 Mar. 2010

SOURCE The Lilly MDR-TB Partnership

Back to top

RELATED LINKS
http://www.globalhealth.org/news/article/12157

'/>"/>

SOURCE The Lilly MDR-TB Partnership
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
2. Aspirin Named 8th World Wonder by Majority of Americans
3. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
4. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
5. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
6. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
7. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
8. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting
11. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... 2017  Palladian Health, a leading provider of ... of an opioid management program which assists physicians ... helps stem the growing tide of dependence on ... chronic non-cancer pain (back pain, neck pain, and ... of evidence regarding long-term effectiveness. The ...
(Date:1/19/2017)... , Jan. 19, 2017 ... Summary GlobalData,s new report, "Germany Cataract Surgery ... on the Germany Cataract Surgery Devices market. The report ... units) and average prices (USD) within market segements - ... report also provides company shares and distribution shares data ...
(Date:1/19/2017)... SILVER SPRING, Md. , Jan. 19, 2017 ... for the treatment of Chronic Idiopathic Constipation (CIC) in adult ... patients suffering from chronic gastrointestinal disorders," said Julie Beitz ... in the FDA,s Center for Drug Evaluation and Research. "With ... select the most appropriate treatment for their condition." ...
Breaking Medicine Technology:
(Date:1/21/2017)... ... January 21, 2017 , ... Santa Rosa Orthopaedics (SRO) is ... at 167 Lynch Creek Way. The Petaluma office features three comfortable patient exam ... rehabilitation services and on-site x-ray services. Two multi-specialist orthopaedic surgeons Dr. Neema ...
(Date:1/21/2017)... Texas (PRWEB) , ... January 21, 2017 , ... ... performed by Austin, Texas Periodontist Dr. Dan Holtzclaw in media for its creos™ ... features two surgeries performed by Dr. Holtzclaw in which he utilizes creos™ allo.gain™ ...
(Date:1/20/2017)... ... ... A new partnership between Goodwill® and Roadie, Inc. aims to make it easier ... couches to dressers and bicycles. Roadie — the national on-the-way delivery network — will ... through February 28th. , “January is an exciting time when resolutions are made ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and body ... oils, announced the company had a successful visit to the 2017 ECRM Diet, Vitamin ... companies that work in the nutritional, sports and health industries a chance to meet ...
(Date:1/20/2017)... ... ... Sports Nutrition LLC, an American company devoted to developing high-quality nutritional supplements for people ... in Hilton Head, SC. , Bionic Sports Nutrition manufactures its entire line of ... clients at reasonable prices. At the ECRM trade show, it had a unique chance ...
Breaking Medicine News(10 mins):